Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA rejects Y-mAbs Therapeutics pediatric cancer drug Omburtamab

Ruchika Sharma3 Dec 2022 1:30 PM IST

Omburtamab was being developed to treat cancer in the cerebrospinal fluid that provides nutrients and chemicals to the brain and spinal cord.

AstraZeneca to Invest USD 15 Billion in China by 2030

AstraZeneca to buy Neogene Therapeutics for over Rs 2605 crore

Ruchika Sharma3 Dec 2022 12:15 PM IST

Neogene will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam, the Netherlands and California, US.

Orchid Pharma to raise Rs 500 crore from institutional investors

Ruchika Sharma3 Dec 2022 11:15 AM IST

New Delhi: Drug firm Orchid Pharma on Thursday said its board has approved to raise Rs 500 crore from institutional investors.The company's board has...

Supreme Court Refuses PIL on Medical Syllabus, Asks to Approach the University or Government

Hospitals, medical stores must be run by registered pharmacists only: SC lashes out at Bihar Govt, Pharmacy Council

Ruchika Sharma2 Dec 2022 5:00 PM IST

"Running the hospitals and dispensaries in the absence of any registered pharmacist and/or running such hospitals by the fake pharmacists and even...

Zydus Lifesciences secures USFDA approval for Estradiol Transdermal System to treat menopause symptoms

Ruchika Sharma2 Dec 2022 3:43 PM IST

Ahmedabad: Pharma major Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has announced that the company has received final ...

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche to stop all Gantenerumab studies in early Alzheimer's disease

Ruchika Sharma2 Dec 2022 2:30 PM IST

Roche is still testing a different formulation of gantenerumab called trontinemab, designed to ferry the drug across the blood brain barrier -...

CDSCO nod to World's first intra-nasal COVID vaccine for restricted use

Ruchika Sharma2 Dec 2022 12:00 PM IST

Vaccine is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.

Johnson & Johnson CEO Joaquin Duato elected as new Chairman of Board

Ruchika Sharma2 Dec 2022 11:00 AM IST

New Brunswick: Johnson & Johnson has announced that its Board of Directors has elected Chief Executive Officer, Joaquin Duato, to assume the...

Alembic Pharma gets four USFDA observations for Panelav facility

Alembic Pharma osteoarthritis drug gets USFDA okay

Ruchika Sharma1 Dec 2022 5:45 PM IST

Diclofenac Sodium Topical Solution is indicated for the treatment of the pain of osteoarthritis of the knee(s).

Sanofi, JnJ, Amgen in talks to acquire Horizon Therapeutics

Ruchika Sharma1 Dec 2022 4:33 PM IST

Bengaluru: Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for...

COVID-19 Treatment : Eli Lilly's Bebtelovimab no longer authorized by USFDA

Ruchika Sharma1 Dec 2022 3:30 PM IST

Eli Lilly and its authorized distributors have paused the commercial distribution of the monoclonal antibody until further notice from the agency.

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Biophore India Pharma, Akum Drugs and Pharma and 1 other ink pact for research of range of products for multiple therapies

Ruchika Sharma1 Dec 2022 2:15 PM IST

New Delhi: Akums Drugs & Pharmaceuticals has announced that it has partnered with Leiutis Pharmaceuticals LLP and Biophore India Pharmaceuticals...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok